Francis Benn, MD
Clinical Cardiac Electrophysiology · Birmingham, ALNPI 1972842201
Payments from drug & device makers
What this record shows
This record is dominated by grants: $64,827 of the $95,080 with a category attached, or 68.2%. 23 manufacturers reported payments, led by Abbott at 44.8% of the total. Reporting peaked in 2021 at $41,672 and has fallen 79.2% since, to $8,685 in 2025. Among clinical cardiac electrophysiology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $329.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$43K
- Medtronic$33K
- Biosense Webster, Inc.$9K
- Biotronik Inc.$5K
- Boston Scientific$3K
- Medical Device Business Services, Inc.$753
- plus $2K from 17 others
What the payments were for
- Consulting fees$7,5008%
- Grants$64,82768%
- Travel & lodging$11,84312%
- Food & beverage$9,90710%
- Education$1,0031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $42,599 |
| Medtronic(2 entities) | 79 | $32,776 |
| Biosense Webster, Inc. | 67 | $9,458 |
| Biotronik Inc. | 28 | $5,340 |
| Boston Scientific | 27 | $2,622 |
| Medical Device Business Services, Inc. | 5 | $753 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $495 |
| Pfizer | 12 | $210 |
| E.r. Squibb & Sons, L.L.C. | 10 | $161 |
| Inari Medical, Inc. | 2 | $148 |
| Astellas Pharma US Inc | 1 | $100 |
| Bayer | 4 | $88 |
| Johnson & Johnson | 4 | $80 |
| Boehringer Ingelheim | 3 | $42 |
| Amgen | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| Impulse Dynamics (USA) Inc. | 2 | $30 |
| Elutia, Inc. | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Altathera Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$8,328
- TactiCath SE$6,750
- Assurity Pacemaker$6,750
- Micra$3,135
- Arctic Front$1,880
- GENERAL - THERAPIES$1,047
- ENSITE PRECISION$652
- WATCHMAN Access System$521
- Ensite Cardiac Mapping System$386
- Solia$280
- BioMonitor$280
- Edora 8 DR-T$280
- Acticor 7 VR-T DX$280
- Rivacor 7 DR-T$280
- Carto 3 System$261
- EnSite Precision Cardiac Mapping System$225
- Confirm Rx$174
- COBALT DR MRI SURESCAN$165
- QUARTET$160
- AZURE XT DR MRI SURESCAN$142
How this compares
$95,080 in reported general payments places this provider in the 90th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 340 | $293,752 |
| MultaqDronedarone Hcl | 66 | $66,989 |
| XareltoRivaroxaban | 64 | $55,979 |
| EntrestoSacubitril/Valsartan | 19 | $15,078 |
| Flecainide Acetate | 156 | $9,285 |
| Amiodarone Hcl | 128 | $3,690 |
| Metoprolol Succinate | 242 | $3,270 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 48 | $943 |
| Carvedilol | 88 | $883 |
| Verapamil ErVerapamil Hcl | 28 | $840 |
| Metoprolol Tartrate | 55 | $405 |
| Atorvastatin Calcium | 19 | $378 |
| Spironolactone | 11 | $225 |
| Potassium Chloride | 11 | $175 |
| Pantoprazole Sodium | 22 | $155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $210 | $293,752340 claims |
| Sanofi-aventis U.S. LLCMultaq | $17 | $66,98966 claims |
| Johnson & JohnsonXarelto | $80 | $55,97964 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Birmingham
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Terence DunnBirmingham$73K
- Byron ColleyBirmingham$59K
- Macy SmithBirmingham$45K
- Chad ColonBirmingham$42K
- Blake SmithBirmingham$36K
- Ahmad JalladBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.